The effect of tumor location on overall survival for pT2-4 bladder and upper tract urothelial carcinoma following radical surgery
Open Access
- 26 October 2020
- journal article
- research article
- Published by Canadian Urological Association Journal in Canadian Urological Association Journal
- Vol. 15 (5), E248-E255
- https://doi.org/10.5489/cuaj.6698
Abstract
Introduction: Historically, staging and treatment for upper tract urothelial carcinoma were extrapolated from bladder urothelial carcinoma literature. However, embryological, genetic, and anatomical differences exist between them. We sought to explore the relationship between location of urothelial cancer and overall survival (OS). Methods: Data was culled from the National Cancer Database from 2004–2015. Patients with pT2-pT4 treated with definitive surgery were included; those with metastatic disease or who received neoadjuvant or adjuvant treatment were excluded. Patients were stratified by tumor location and pathological stage. The primary outcome was OS. Secondary outcomes were predictors of mortality in each pT stage stratum. Results: A total of 11 330 patients with bladder, 954 patients with ureteral, and 1943 patients with renal pelvis urothelial carcinoma were analyzed. Mean followup was 43.3, 39.4, and 41.4 months for bladder, ureteral, and renal pelvis, respectively. On univariable analysis, ureteral pT2 was associated with worse OS compared to both bladder (61.3 vs. 80.4 months, p=0.007) and renal pelvis (61.3 vs. 80.5 months, p=0.014). Renal pelvis pT3 was associated with improved OS compared to both bladder (42.5 vs. 28.6 months, p=0.003) and ureteral (42.5 vs. 25.7 months, pConclusions: Renal pelvis pT3 is associated with lower mortality. Mutational and embryological differences may play a role in this disparity.Keywords
This publication has 24 references indexed in Scilit:
- Subclassification of pT3 Urothelial Carcinoma of the Renal Pelvicalyceal System is Associated With Recurrence-Free and Cancer-Specific Survival: Proposal for a Revision of the Current TNM ClassificationEuropean Urology, 2012
- Prognostic Factors in Upper Urinary Tract Urothelial Carcinomas: A Comprehensive Review of the Current LiteratureEuropean Urology, 2012
- Ureteral and Multifocal Tumours Have Worse Prognosis than Renal Pelvic Tumours in Urothelial Carcinoma of the Upper Urinary Tract Treated by NephroureterectomyEuropean Urology, 2011
- The Effect of Tumor Location on Prognosis in Patients Treated with Radical Nephroureterectomy at Memorial Sloan-Kettering Cancer CenterEuropean Urology, 2010
- Impact of Tumor Location on Prognosis for Patients with Upper Tract Urothelial Carcinoma Managed by Radical NephroureterectomyEuropean Urology, 2010
- Outcome of Surgical Treatment of Patients with Upper versus Lower Urinary Tract Urothelial Carcinoma: Stage-by-Stage ComparisonUrologia Internationalis, 2010
- Estrogen and Progesterone Hormonal Receptor Expression in Urothelial Carcinoma of the BladderEuropean Urology, 2009
- Location of the Primary Tumor is Not an Independent Predictor of Cancer Specific Mortality in Patients With Upper Urinary Tract Urothelial CarcinomaJournal of Urology, 2009
- Behavior of Urothelial Carcinoma With Respect to Anatomical LocationJournal of Urology, 2007
- Prognostic Significance of Bladder Tumor History and Tumor Location in Upper Tract Transitional Cell CarcinomaJournal of Urology, 2006